ViroPharma (VPHM) Could Draw 50% Premium in Takeover
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street set for lower open as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Deutsche Bank Cuts ViroPharma (VPHM) to Hold; Takeout Premium Reflected in Price
September 19, 2013 7:28 AM EDTDeutsche Bank downgraded ViroPharma (NASDAQ: VPHM) from Buy to Hold with a price target of $43.00 (from $38.00). Analyst Robyn Karnauskas thinks the stock's current price reflects most of the M&A takeout premium.
"Press sources on 9/13 (Bloomberg) stated that Viropharma has hired... More
UPDATE: ViroPharma Inc. (VPHM) Hires Goldman to Explore Sale - Bloomberg
September 13, 2013 1:00 PM EDT(Updated - September 13, 2013 1:08 PM EDT)
ViroPharma Inc. (Nasdaq: VPHM) has attracted takeover interest from Sanofi (NYSE: SNY) and Shire (NYSE: SHPG), according to Bloomberg sources. The company has hired Goldman Sachs to manage a potential auction, and the Bank has is seeking other bidders.... More
